Key facts
- TechForce Robotics has entered the pharmaceutical and laboratory automation market.
- The company's AI-enhanced robotics platform, LIM-E, was deployed at Oncotelic Therapeutics.
- This marks TechForce's expansion beyond hospitality and service industries.
- The deployment highlights the platform's adaptability for efficiency and workflow optimization.
TechForce Robotics' expansion into the pharmaceutical sector signifies a strategic move to leverage its AI-enhanced robotics for high-value applications. The successful deployment of its LIM-E platform at Oncotelic Therapeutics demonstrates the technology's versatility in environments demanding precision and efficiency, potentially opening new avenues for growth in specialized industries.